H-Index
75
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
18%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo



eISSN: 1643-3750

Get your full text copy in PDF

Relationship between interleukin-1beta and lipids in type 1 diabetic patients

Mourad Aribi, Soraya Moulessehoul, Mohammed Kendouci-Tani, Ahmed-Bakir Benabadji, Aziz Hichami, Naim Akhtar Khan

Med Sci Monit 2007; 13(8): CR372-378

ID: 491658


Background:    The auto-immune response leading to type 1 diabetes (T1D) is closely associated with the overproduction of T helper-1 (Th1) cytokines which activate macrophage production of inflammatory mediators such as interleukin (IL)-1beta. The principal aim of this study was to elucidate whether IL-1beta is associated with the development of the inflammatory state of disease and the altered circulating lipid levels in T1D.
    Material/Methods:    Sixty-nine T1D and 74 age-matched non-diabetic (ND) subjects were recruited from the outpatient department of Internal Medicine, University Medical Center, Tlemcen, Algeria.
    Results:    The levels of IL-1beta, CRP, HbA1c, CHOL, and LDLc, but not of HDLc, were significantly higher in all T1D subjects than in the ND controls. IL-1beta and CRP were found to be associated with T1D (OR>1). Newly diagnosed T1D subjects exhibited significantly higher IL-1beta, but not CRP, concentrations than controls and long-standing diabetic subjects. TG and HbA1c levels were not statistically different in the two diabetic populations. However, CHOL and LDLc concentrations were significantly higher in long-standing patients than in newly diagnosed ones. HDLc fractions were lower in long-standing patients than in controls and newly diagnosed diabetic subjects. Furthermore, the plasmatic concentrations of IL-1beta, but not of CRP, negatively correlated with CHOL, LDLc, or TG levels and positively with those of CRP in T1D patients.
    Conclusions:    IL-1beta seems to be associated with the type 1 diabetes inflammatory process. Moreover, a reciprocal relationship exists between newly diagnosed and long-standing T1D patients as far as the levels of this cytokine and circulating lipids are concerned.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree